A Collaborative Approach To Viral Vector Development And Manufacturing

Gene therapies hold the potential to address rare, genetic diseases with previously unmet medical needs. Translating these discoveries into viable treatments hinges on the use of viral vectors — delivery vehicles that have radically changed the face of medicine. However, the development and large-scale manufacturing of viral vectors from discovery to commercialization is a complicated endeavor with many moving parts.

Learn how partnering with an experienced CDMO can reduce costs, mitigate risk, and shorten development timelines, helping to deliver life-saving products to patients in need.